首页 | 官方网站   微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   25990篇
  免费   1299篇
  国内免费   164篇
医药卫生   27453篇
  2023年   126篇
  2022年   104篇
  2021年   531篇
  2020年   303篇
  2019年   384篇
  2018年   528篇
  2017年   416篇
  2016年   522篇
  2015年   531篇
  2014年   775篇
  2013年   869篇
  2012年   1469篇
  2011年   1649篇
  2010年   938篇
  2009年   835篇
  2008年   1488篇
  2007年   1646篇
  2006年   1634篇
  2005年   1757篇
  2004年   1776篇
  2003年   1778篇
  2002年   1669篇
  2001年   407篇
  2000年   381篇
  1999年   428篇
  1998年   440篇
  1997年   350篇
  1996年   348篇
  1995年   297篇
  1994年   266篇
  1993年   234篇
  1992年   253篇
  1991年   223篇
  1990年   192篇
  1989年   190篇
  1988年   183篇
  1987年   164篇
  1986年   143篇
  1985年   144篇
  1984年   136篇
  1983年   102篇
  1982年   91篇
  1981年   85篇
  1980年   81篇
  1979年   90篇
  1978年   61篇
  1977年   63篇
  1976年   44篇
  1975年   42篇
  1974年   40篇
排序方式: 共有10000条查询结果,搜索用时 150 毫秒
1.
International Journal of Clinical Oncology - The practice of cancer diagnosis disclosure to children has been changed with the times. The regulations of clinical trials in the 2000s might change...  相似文献   
2.
Finasteride is standard medical treatment for androgenetic alopecia; however, no large studies with 5 years or more of follow up have been performed in Japan. The authors followed Japanese men with androgenetic alopecia treated with finasteride for 5 years to evaluate long‐term treatment efficacy. Of 903 men treated with finasteride (1 mg/day), 801 patients were evaluated over 5 years by modified global photographic assessment. Although the proportion of improvement was high (99.4%), modified global photographic assessment scores after 5 years of treatment were lower in patients with more advanced disease as measured by the modified Norwood–Hamilton scale. After separating patients into “sufficient” and “insufficient” efficacy groups according to the modified global photographic assessment score after 5 years (scores ≥6 and <6, respectively), multivariate analysis showed that independent risk factors of insufficient efficacy were age at start of treatment of 40 years or more (P = 0.021) and classification on the modified Norwood–Hamilton scale (P < 0.001), whereas presence of stress at start of treatment was a negative predictor (P = 0.025). In conclusion, continuous finasteride treatment for 5 years improved androgenetic alopecia with sustained effect among Japanese. Younger age and less advanced disease at start of treatment were the key predictors of higher finasteride efficacy.  相似文献   
3.
4.
5.
Purpose: Small pulmonary lesions that include ground-glass attenuation have been increasingly discovered because of progressive imaging diagnostic technologies. Despite the detection of such small lesions, sometimes it is quite difficult to localize them because of their size or considerable depth from the visceral pleura. In the present study, we examined the usefulness of computed tomography-guided lipiodol marking for thoracoscopic resection of impalpable pulmonary nodules.Methods: Fifty-six patients with an undiagnosed peripheral lesion(s) of the lung who had undergone preoperative computed tomography-guided lipiodol marking followed by video-assisted thoracoscopic surgery were studied.Results: All of the nodules were successfully marked by computed tomography-guided lipiodol marking, and all except for one case were localized by means of intraoperative fluoroscopy as clear spots. With regard to complications, pneumothorax occurred in 21 patients (37.5%), and only one patient required transient drainage. Although hemorrhaging in the lung parenchyma and hemosputum occurred in nine patients (16.1%) and one patient (1.8%), respectively, no patients were in serious condition. No intra- or postoperative mortality or morbidity was observed.Conclusion: Preoperative computed tomography-guided lipiodol marking of small or impalpable pulmonary nodules is a safe and useful procedure for thoracoscopic resection of the lung.  相似文献   
6.
Journal of Neurology -  相似文献   
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号